Market Currents
Halozyme Therapeutics (HALO) hooks up with Pfizer (PFE) to develop and market products combining...
-
Friday, December 21, 2012, 7:45 AM ETHalozyme Therapeutics (HALO) hooks up with Pfizer (PFE) to develop and market products combining Halozyme's rHuPH20 with Pfizer's proprietary biologics. Halozyme receives an upfront payment of $8M, and future payments of up to $507M will depend on Pfizer's reaching of certain targets. (PR)
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
